DEVIREX AG has a total of 23 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2008. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets pharmaceuticals are SOLVON ARZNEI VERTRIEB LIZENZ, THERANEXUS and CHARLESTON LAB INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 3 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | China | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Israel | 2 | |
#7 | Mexico | 2 | |
#8 | Singapore | 2 | |
#9 | Brazil | 1 | |
#10 | Hong Kong | 1 | |
#11 | Republic of Korea | 1 | |
#12 | Serbia | 1 | |
#13 | United States | 1 | |
#14 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Langenauer Marcel | 19 |
#2 | Vitins Peter | 19 |
#3 | Scherer Paul Martin | 13 |
#4 | Peter Vitins | 2 |
#5 | Marcel Langenauer | 2 |
Publication | Filing date | Title |
---|---|---|
WO2013102885A1 | Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster | |
KR20130142992A | Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster | |
BRPI0806633A2 | gel composition, spray composition, nasal gel composition, lip balm composition, emulsified composition, pharmaceutical or cosmetic composition for application to a wave site is an active primary viral infection or known site that exhibits a recurrent viral infection |